NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT04163185,Initiating Early Control of Migraine Pain and Associated Symptoms,https://clinicaltrials.gov/study/NCT04163185,INTERCEPT,COMPLETED,"AXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in adults. AXS-07 tablets are formulated to provide an enhanced rate of absorption of meloxicam. This study is designed to evaluate the efficacy and safety of AXS-07 compared to placebo.

This is a randomized, double-blind, single-dose, placebo-controlled trial. Subjects who successfully complete the screening period and continue to meet all entry criteria will be randomly assigned to take one dose of either AXS-07 or placebo upon the earliest onset of migraine pain.",NO,Migraine,DRUG: AXS-07 (MoSEIC meloxicam and rizatriptan)|DRUG: Placebo,"Percentage of subjects reporting headache pain freedom, Absence of headache pain, Hour 2|Percentage of subjects with absence of Most Bothersome Symptom, Absence of Most Bothersome Symptom, defined at the onset of migraine, Hour 2",,,"Axsome Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,302,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",AXS-07-303,2019-10-08,2020-03-23,2020-03-23,2019-11-14,,2021-04-30,"Clinical Research Site, Birmingham, Alabama, 35205, United States|Clinical Research Site, Birmingham, Alabama, 35216, United States|Clinical Research Site, Mobile, Alabama, 36608, United States|Clinical Research Site, Colton, California, 92399, United States|Clinical Research Site, Encino, California, 91316, United States|Clinical Research Site, Los Alamitos, California, 90720, United States|Clinical Research Site, Los Angeles, California, 90017, United States|Clinical Research Site, Redlands, California, 92374, United States|Clinical Research Site, Santa Monica, California, 90404, United States|Clinical Research Site, Spring Valley, California, 91978, United States|Clinical Research Site, Walnut Creek, California, 94598, United States|Clinical Research Site, Hallandale Beach, Florida, 33009, United States|Clinical Research Site, Jacksonville, Florida, 32256, United States|Clinical Research Site, Lake City, Florida, 32055, United States|Clinical Research Site, Lake Worth, Florida, 33467, United States|Clinical Research Site, Ocoee, Florida, 34761, United States|Clinical Research Site, Orlando, Florida, 32801, United States|Clinical Research Site, Ormond Beach, Florida, 32174, United States|Clinical Research Site, South Miami, Florida, 33143, United States|Clinical Research Site, Sunrise, Florida, 33351, United States|Clinical Research Site, Tampa, Florida, 33634, United States|Clinical Research Site, Stockbridge, Georgia, 30281, United States|Clinical Research Site, Evanston, Illinois, 60201, United States|Clinical Research Site, Louisville, Kentucky, 40213, United States|Clinical Research Site, Boston, Massachusetts, 02131, United States|Clinical Research Site, Waltham, Massachusetts, 02451, United States|Clinical Research Site, Ann Arbor, Michigan, 48104, United States|Clinical Research Site, Springfield, Missouri, 65810, United States|Clinical Research Site, Albuquerque, New Mexico, 87102, United States|Clinical Research Site, Manlius, New York, 13104, United States|Clinical Research Site, Williamsville, New York, 14221, United States|Clinical Research Site, High Point, North Carolina, 27262, United States|Clinical Research Site, Oklahoma City, Oklahoma, 73106, United States|Clinical Research Site, Philadelphia, Pennsylvania, 19114, United States|Clinical Research Site, Charleston, South Carolina, 29406, United States|Clinical Research Site, Mount Pleasant, South Carolina, 29464, United States|Clinical Research Site, Memphis, Tennessee, 38119, United States|Clinical Research Site, Nashville, Tennessee, 37203, United States|Clinical Research Site, Austin, Texas, 78731, United States|Clinical Research Site, Salt Lake City, Utah, 84107, United States|Clinical Research Site, Charlottesville, Virginia, 22911, United States",
